Nerve  ||| S:0 E:6 ||| NNP
Regeneration  ||| S:6 E:19 ||| NNP
Potential  ||| S:19 E:29 ||| NNP
of  ||| S:29 E:32 ||| IN
Protocatechuic  ||| S:32 E:47 ||| NNP
Acid  ||| S:47 E:52 ||| NNP
in  ||| S:52 E:55 ||| IN
RSC96  ||| S:55 E:61 ||| NNP
Schwann  ||| S:61 E:69 ||| NNP
Cells  ||| S:69 E:75 ||| NNP
by  ||| S:75 E:78 ||| IN
Induction  ||| S:78 E:88 ||| NNP
of  ||| S:88 E:91 ||| IN
Cellular  ||| S:91 E:100 ||| NNP
Proliferation  ||| S:100 E:114 ||| NNP
and  ||| S:114 E:118 ||| CC
Migration  ||| S:118 E:128 ||| NNP
through  ||| S:128 E:136 ||| IN
IGF-IR-PI3K-Akt  ||| S:136 E:152 ||| NNP
Signaling  ||| S:152 E:162 ||| NNP
Peripheral  ||| S:162 E:173 ||| NNP
nerve  ||| S:173 E:179 ||| NN
injuries ||| S:179 E:187 ||| NNS
,  ||| S:187 E:189 ||| ,
caused  ||| S:189 E:196 ||| VBN
by  ||| S:196 E:199 ||| IN
accidental  ||| S:199 E:210 ||| JJ
trauma ||| S:210 E:216 ||| NN
,  ||| S:216 E:218 ||| ,
acute  ||| S:218 E:224 ||| JJ
compression  ||| S:224 E:236 ||| NN
or  ||| S:236 E:239 ||| CC
surgery ||| S:239 E:246 ||| NN
,  ||| S:246 E:248 ||| ,
often  ||| S:248 E:254 ||| RB
result  ||| S:254 E:261 ||| VB
in  ||| S:261 E:264 ||| IN
temporary  ||| S:264 E:274 ||| JJ
or  ||| S:274 E:277 ||| CC
life-long  ||| S:277 E:287 ||| JJ
neuronal  ||| S:287 E:296 ||| JJ
dysfunctions  ||| S:296 E:309 ||| NN
and  ||| S:309 E:313 ||| CC
inflict  ||| S:313 E:321 ||| VB
great  ||| S:321 E:327 ||| JJ
economic  ||| S:327 E:336 ||| JJ
or  ||| S:336 E:339 ||| CC
social  ||| S:339 E:346 ||| JJ
burdens  ||| S:346 E:354 ||| NNS
on  ||| S:354 E:357 ||| IN
the  ||| S:357 E:361 ||| DT
patients ||| S:361 E:369 ||| NNS
.  ||| S:369 E:371 ||| .
Nerve  ||| S:371 E:377 ||| JJ
cell  ||| S:377 E:382 ||| NN
proliferation  ||| S:382 E:396 ||| NN
is  ||| S:396 E:399 ||| VBZ
an  ||| S:399 E:402 ||| DT
essential  ||| S:402 E:412 ||| JJ
process  ||| S:412 E:420 ||| NN
to  ||| S:420 E:423 ||| TO
restore  ||| S:423 E:431 ||| VB
injured  ||| S:431 E:439 ||| VBN
nerves  ||| S:439 E:446 ||| NNS
of  ||| S:446 E:449 ||| IN
adults ||| S:449 E:455 ||| NNS
.  ||| S:455 E:457 ||| .
Schwann  ||| S:457 E:465 ||| JJ
cells  ||| S:465 E:471 ||| NNS
play  ||| S:471 E:476 ||| VBP
a  ||| S:476 E:478 ||| DT
crucial  ||| S:478 E:486 ||| JJ
role  ||| S:486 E:491 ||| NN
in  ||| S:491 E:494 ||| IN
endogenous  ||| S:494 E:505 ||| JJ
repair  ||| S:505 E:512 ||| NN
of  ||| S:512 E:515 ||| IN
peripheral  ||| S:515 E:526 ||| JJ
nerves  ||| S:526 E:533 ||| NNS
due  ||| S:533 E:537 ||| JJ
to  ||| S:537 E:540 ||| TO
their  ||| S:540 E:546 ||| PRP$
ability  ||| S:546 E:554 ||| NN
to  ||| S:554 E:557 ||| TO
proliferate ||| S:557 E:568 ||| VB
,  ||| S:568 E:570 ||| ,
migrate  ||| S:570 E:578 ||| NN
and  ||| S:578 E:582 ||| CC
provide  ||| S:582 E:590 ||| VB
trophic  ||| S:590 E:598 ||| JJ
support  ||| S:598 E:606 ||| NN
to  ||| S:606 E:609 ||| TO
axons  ||| S:609 E:615 ||| VB
via  ||| S:615 E:619 ||| IN
expression  ||| S:619 E:630 ||| NN
of  ||| S:630 E:633 ||| IN
various  ||| S:633 E:641 ||| JJ
neurotrophic  ||| S:641 E:654 ||| JJ
factors ||| S:654 E:661 ||| NNS
,  ||| S:661 E:663 ||| ,
such  ||| S:663 E:668 ||| JJ
as  ||| S:668 E:671 ||| IN
the  ||| S:671 E:675 ||| DT
nerve  ||| S:675 E:681 ||| NN
growth  ||| S:681 E:688 ||| NN
factor  ||| S:688 E:695 ||| NN
( ||| S:695 E:696 ||| -LRB-
NGF ||| S:696 E:699 ||| NNP
) ||| S:699 E:700 ||| -RRB-
,  ||| S:700 E:702 ||| ,
especially  ||| S:702 E:713 ||| RB
after  ||| S:713 E:719 ||| IN
nerve  ||| S:719 E:725 ||| JJ
injury ||| S:725 E:731 ||| NN
.  ||| S:731 E:733 ||| .
Protocatechuic  ||| S:733 E:748 ||| JJ
acid  ||| S:748 E:753 ||| NN
( ||| S:753 E:754 ||| -LRB-
PCA ||| S:754 E:757 ||| NNP
)  ||| S:757 E:759 ||| -RRB-
is  ||| S:759 E:762 ||| VBZ
a  ||| S:762 E:764 ||| DT
dihydroxybenzoic  ||| S:764 E:781 ||| JJ
acid ||| S:781 E:785 ||| NN
,  ||| S:785 E:787 ||| ,
a  ||| S:787 E:789 ||| DT
type  ||| S:789 E:794 ||| NN
of  ||| S:794 E:797 ||| IN
phenolic  ||| S:797 E:806 ||| JJ
acid ||| S:806 E:810 ||| NN
,  ||| S:810 E:812 ||| ,
isolated  ||| S:812 E:821 ||| VBN
from  ||| S:821 E:826 ||| IN
the  ||| S:826 E:830 ||| DT
kernels  ||| S:830 E:838 ||| NN
of  ||| S:838 E:841 ||| IN
Alpinia  ||| S:841 E:849 ||| NNP
oxyphylla  ||| S:849 E:859 ||| FW
Miq  ||| S:859 E:863 ||| FW
( ||| S:863 E:864 ||| -LRB-
AOF ||| S:864 E:867 ||| NNP
) ||| S:867 E:868 ||| -RRB-
,  ||| S:868 E:870 ||| ,
a  ||| S:870 E:872 ||| DT
traditional  ||| S:872 E:884 ||| JJ
Chinese  ||| S:884 E:892 ||| JJ
herbal  ||| S:892 E:899 ||| JJ
medicine  ||| S:899 E:908 ||| NN
the  ||| S:908 E:912 ||| DT
fruits  ||| S:912 E:919 ||| NNS
of  ||| S:919 E:922 ||| IN
which  ||| S:922 E:928 ||| WDT
are  ||| S:928 E:932 ||| VBP
widely  ||| S:932 E:939 ||| RB
used  ||| S:939 E:944 ||| VBN
as  ||| S:944 E:947 ||| IN
a  ||| S:947 E:949 ||| DT
tonic ||| S:949 E:954 ||| NN
,  ||| S:954 E:956 ||| ,
aphrodisiac ||| S:956 E:967 ||| NN
,  ||| S:967 E:969 ||| ,
anti-salivation  ||| S:969 E:985 ||| JJ
and  ||| S:985 E:989 ||| CC
anti-diarrheatic ||| S:989 E:1005 ||| JJ
.  ||| S:1005 E:1007 ||| .
This  ||| S:1007 E:1012 ||| DT
study  ||| S:1012 E:1018 ||| NN
investigated  ||| S:1018 E:1031 ||| VBD
the  ||| S:1031 E:1035 ||| DT
molecular  ||| S:1035 E:1045 ||| JJ
mechanisms  ||| S:1045 E:1056 ||| NNS
by  ||| S:1056 E:1059 ||| IN
which  ||| S:1059 E:1065 ||| WDT
PCA  ||| S:1065 E:1069 ||| NNP
induces  ||| S:1069 E:1077 ||| VBZ
Schwann  ||| S:1077 E:1085 ||| JJ
cell  ||| S:1085 E:1090 ||| NN
proliferation  ||| S:1090 E:1104 ||| NN
by  ||| S:1104 E:1107 ||| IN
activating  ||| S:1107 E:1118 ||| CD
IGF-IR-PI3K-Akt  ||| S:1118 E:1134 ||| CD
pathway ||| S:1134 E:1141 ||| NNS
.  ||| S:1141 E:1143 ||| .
Treatment  ||| S:1143 E:1153 ||| NN
with  ||| S:1153 E:1158 ||| IN
PCA  ||| S:1158 E:1162 ||| NNP
induces  ||| S:1162 E:1170 ||| VBZ
phosphorylation  ||| S:1170 E:1186 ||| VBN
of  ||| S:1186 E:1189 ||| IN
the  ||| S:1189 E:1193 ||| DT
insulin-like  ||| S:1193 E:1206 ||| JJ
growth  ||| S:1206 E:1213 ||| NN
factor-I  ||| S:1213 E:1222 ||| NNS
( ||| S:1222 E:1223 ||| -LRB-
IGF-I ||| S:1223 E:1228 ||| NNP
) ||| S:1228 E:1229 ||| -RRB-
-mediated  ||| S:1229 E:1239 ||| JJ
phosphatidylinositol  ||| S:1239 E:1260 ||| NN
3  ||| S:1260 E:1262 ||| CD
kinase ||| S:1262 E:1268 ||| CD
/ ||| S:1268 E:1269 ||| CD
serine  ||| S:1269 E:1276 ||| NNS
-  ||| S:1276 E:1278 ||| :
threonine  ||| S:1278 E:1288 ||| FW
kinase  ||| S:1288 E:1295 ||| FW
( ||| S:1295 E:1296 ||| -LRB-
PI3K ||| S:1296 E:1300 ||| NNP
/ ||| S:1300 E:1301 ||| NNP
Akt ||| S:1301 E:1304 ||| NNP
)  ||| S:1304 E:1306 ||| -RRB-
pathway ||| S:1306 E:1313 ||| NN
,  ||| S:1313 E:1315 ||| ,
and  ||| S:1315 E:1319 ||| CC
activates  ||| S:1319 E:1329 ||| JJ
expression  ||| S:1329 E:1340 ||| NN
of  ||| S:1340 E:1343 ||| IN
cell  ||| S:1343 E:1348 ||| NN
nuclear  ||| S:1348 E:1356 ||| JJ
antigen  ||| S:1356 E:1364 ||| NN
( ||| S:1364 E:1365 ||| -LRB-
PCNA ||| S:1365 E:1369 ||| NNP
)  ||| S:1369 E:1371 ||| -RRB-
in  ||| S:1371 E:1374 ||| IN
a  ||| S:1374 E:1376 ||| DT
dose-dependent  ||| S:1376 E:1391 ||| JJ
manner ||| S:1391 E:1397 ||| NN
.  ||| S:1397 E:1399 ||| .
Cell  ||| S:1399 E:1404 ||| NN
cycle  ||| S:1404 E:1410 ||| NN
analysis  ||| S:1410 E:1419 ||| NN
after  ||| S:1419 E:1425 ||| IN
18  ||| S:1425 E:1428 ||| CD
h  ||| S:1428 E:1430 ||| NN
of  ||| S:1430 E:1433 ||| IN
treatment  ||| S:1433 E:1443 ||| NN
showed  ||| S:1443 E:1450 ||| VBD
that  ||| S:1450 E:1455 ||| DT
proliferation  ||| S:1455 E:1469 ||| NN
of  ||| S:1469 E:1472 ||| IN
the  ||| S:1472 E:1476 ||| DT
RSC96  ||| S:1476 E:1482 ||| CD
cells  ||| S:1482 E:1488 ||| NNS
was  ||| S:1488 E:1492 ||| VBD
enhanced  ||| S:1492 E:1501 ||| VBN
by  ||| S:1501 E:1504 ||| IN
PCA  ||| S:1504 E:1508 ||| NNP
treatment ||| S:1508 E:1517 ||| NN
.  ||| S:1517 E:1519 ||| .
The  ||| S:1519 E:1523 ||| DT
PCA  ||| S:1523 E:1527 ||| NNP
induced  ||| S:1527 E:1535 ||| JJ
proliferation  ||| S:1535 E:1549 ||| NN
was  ||| S:1549 E:1553 ||| VBD
accompanied  ||| S:1553 E:1565 ||| VBN
by  ||| S:1565 E:1568 ||| IN
modulation  ||| S:1568 E:1579 ||| NN
in  ||| S:1579 E:1582 ||| IN
the  ||| S:1582 E:1586 ||| DT
expressions  ||| S:1586 E:1598 ||| NNS
of  ||| S:1598 E:1601 ||| IN
cell  ||| S:1601 E:1606 ||| NN
cycle  ||| S:1606 E:1612 ||| NN
proteins  ||| S:1612 E:1621 ||| NNS
cyclin  ||| S:1621 E:1628 ||| VBD
D1 ||| S:1628 E:1630 ||| CD
,  ||| S:1630 E:1632 ||| ,
cyclin  ||| S:1632 E:1639 ||| JJ
E  ||| S:1639 E:1641 ||| NN
and  ||| S:1641 E:1645 ||| CC
cyclin  ||| S:1645 E:1652 ||| JJ
A.  ||| S:1652 E:1655 ||| NNP
Knockdown  ||| S:1655 E:1665 ||| NNP
of  ||| S:1665 E:1668 ||| IN
PI3K  ||| S:1668 E:1673 ||| CD
using  ||| S:1673 E:1679 ||| VBG
small  ||| S:1679 E:1685 ||| JJ
interfering  ||| S:1685 E:1697 ||| JJ
RNA  ||| S:1697 E:1701 ||| NNP
( ||| S:1701 E:1702 ||| -LRB-
siRNA ||| S:1702 E:1707 ||| NNP
)  ||| S:1707 E:1709 ||| -RRB-
and  ||| S:1709 E:1713 ||| CC
inhibition  ||| S:1713 E:1724 ||| NN
of  ||| S:1724 E:1727 ||| IN
IGF-IR  ||| S:1727 E:1734 ||| JJ
receptor  ||| S:1734 E:1743 ||| NN
resulted  ||| S:1743 E:1752 ||| VBD
in  ||| S:1752 E:1755 ||| IN
the  ||| S:1755 E:1759 ||| DT
reduction  ||| S:1759 E:1769 ||| NN
in  ||| S:1769 E:1772 ||| IN
cell  ||| S:1772 E:1777 ||| NN
survival  ||| S:1777 E:1786 ||| NN
proteins ||| S:1786 E:1794 ||| NNS
.  ||| S:1794 E:1796 ||| .
The  ||| S:1796 E:1800 ||| DT
results  ||| S:1800 E:1808 ||| NNS
collectively  ||| S:1808 E:1821 ||| RB
showed  ||| S:1821 E:1828 ||| VBD
that  ||| S:1828 E:1833 ||| IN
PCA  ||| S:1833 E:1837 ||| NNP
treatment  ||| S:1837 E:1847 ||| NN
promoted  ||| S:1847 E:1856 ||| VBN
cell  ||| S:1856 E:1861 ||| NN
proliferation  ||| S:1861 E:1875 ||| NN
and  ||| S:1875 E:1879 ||| CC
cell  ||| S:1879 E:1884 ||| NN
survival  ||| S:1884 E:1893 ||| NN
via  ||| S:1893 E:1897 ||| IN
IGF-I  ||| S:1897 E:1903 ||| JJ
signaling ||| S:1903 E:1912 ||| NN
.  ||| S:1912 E:1914 ||| .
